Management of Venous Thrombosis in a T-Cell Acute Lymphoblastic Leukemia Case with Superior Vena Cava Syndrome

Kaynakça (1)

1. Jain R, Bansal D, Marwaha RK, Singhi S. Superior mediastinal syndrome: emergency management. Indian J Pediatr. 2013;80(1):55- 59. [CrossRef] 2. Swaniker F, Fonkalsrud EW. Superior and inferior vena caval occlusion in infants receiving total parenteral nutrition. Am Surg. 1995;61(10):877-881. 3. Kazanci SY, McElhinney DB, Thiagarajan R, et al. Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med. 2013;14(1):37-43. [CrossRef] 4. Olsen JH, Hahnemann JM, Børresen-Dale AL, et al. Cancer in patients with Ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst. 2001;93(2):121-127. [CrossRef] 5. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by Ataxia-telangiectasia. N Engl J Med. 1991;325(26):1831-1836. [CrossRef]. 6. Nossair F, Schoettler P, Starr J, et al. Pediatric superior vena cava syndrome: an evidence-based systematic review of the literature. Pediatr Blood Cancer. 2018;65(9):e27225. [CrossRef] 7. Ozcan A, Unal E, Karakukcu M, Coskun A, Ozdemir MA, Patiroglu T. Vena cava superior syndrome in the children with mediastinal tumors: single-center experience. North Clin Istanb. 2020;7(3):255-259. [CrossRef]